• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养、基因多态性和肠道微生物群在非酒精性脂肪性肝病中的作用。

Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.

作者信息

Kong Lingbo, Lu Yu, Zhang Siyu, Nan Yuemin, Qiao Liang

机构信息

Department of Traditional and Western Medical Hepatology, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, China.

Storr Liver Centre, Westmead Millennium Institute for Medical Research, the University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.

出版信息

Discov Med. 2017 Sep;24(131):95-106.

PMID:28972878
Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. The nutrients play important roles in the development and progression of NAFLD. High-calorie diet, especially the diet rich in saturated fatty acids and cholesterol, as well as sugary drinks with high fructose content, induces hepatic steatosis and triggers progression of steatohepatitis, fibrosis, and even hepatocellular carcinoma. Disordered micronutrient status and gut microbiota are also involved in the pathogenesis of NAFLD. Nutrients related NAFLD could be aggravated by a genetic predisposition, for instance, genetic mutations in patatinlike phospholipase domain-containing 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2). Reduction of caloric intake through lifestyle interventions and use of dietary supplements such as omega-3 fatty acids, vitamins, and probiotics may help alleviate liver injury in NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是全球最常见的肝脏疾病。营养物质在NAFLD的发生和发展中起着重要作用。高热量饮食,尤其是富含饱和脂肪酸和胆固醇的饮食,以及高果糖含量的含糖饮料,会诱发肝脂肪变性并引发脂肪性肝炎、纤维化甚至肝细胞癌的进展。微量营养素状态紊乱和肠道微生物群也参与了NAFLD的发病机制。与营养物质相关的NAFLD可能会因遗传易感性而加重,例如,含patatin样磷脂酶结构域3(PNPLA3)和跨膜6超家族成员2(TM6SF2)的基因突变。通过生活方式干预减少热量摄入以及使用ω-3脂肪酸、维生素和益生菌等膳食补充剂可能有助于减轻NAFLD中的肝损伤。

相似文献

1
Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.营养、基因多态性和肠道微生物群在非酒精性脂肪性肝病中的作用。
Discov Med. 2017 Sep;24(131):95-106.
2
Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.热量摄入减少可能会抵消脂肪肝患者中PNPLA3基因p.I148M和TM6SF2基因p.E167K变异的促脂肪变性作用:基于超声的前瞻性研究
Digestion. 2016;93(2):139-48. doi: 10.1159/000441185. Epub 2016 Jan 9.
3
Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.营养素、遗传因素及其在非酒精性脂肪性肝病和心血管疾病中的相互作用。
Int J Mol Sci. 2020 Nov 19;21(22):8761. doi: 10.3390/ijms21228761.
4
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial.治疗非酒精性脂肪性肝病中的肝脂肪和血清甘油三酯水平,PNPLA3 和 TM6SF2 基因型的影响:来自 WELCOME 试验的结果。
J Hepatol. 2015 Dec;63(6):1476-83. doi: 10.1016/j.jhep.2015.07.036. Epub 2015 Aug 10.
5
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病 (NAFLD) 中维生素 A 代谢紊乱。
Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029.
6
Low hepatic copper content and PNPLA3 polymorphism in non-alcoholic fatty liver disease in patients without metabolic syndrome.无代谢综合征患者非酒精性脂肪性肝病中的低肝铜含量及PNPLA3基因多态性
J Trace Elem Med Biol. 2017 Jan;39:100-107. doi: 10.1016/j.jtemb.2016.08.006. Epub 2016 Aug 20.
7
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables.促进非酒精性脂肪性肝病的遗传学研究:通过多态性和临床变量联合风险评分。
World J Gastroenterol. 2018 Nov 21;24(43):4835-4845. doi: 10.3748/wjg.v24.i43.4835.
8
Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.日本PNPLA3、TM6SF2基因变异与非酒精性脂肪性肝病组织学特征的关系
Gut Liver. 2016 May 23;10(3):437-45. doi: 10.5009/gnl15163.
9
Diagnosis of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)的诊断
Diabetologia. 2016 Jun;59(6):1104-11. doi: 10.1007/s00125-016-3944-1. Epub 2016 Apr 18.
10
Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease.经活检证实的非酒精性脂肪性肝病中肠道微生物群、饮食与 PNPLA3 多态性的联合分析。
Liver Int. 2021 Jul;41(7):1576-1591. doi: 10.1111/liv.14899. Epub 2021 May 7.

引用本文的文献

1
The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.抗氧化剂在代谢功能障碍相关脂肪性肝病治疗中的作用:一项系统评价
Antioxidants (Basel). 2024 Jun 29;13(7):797. doi: 10.3390/antiox13070797.
2
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.
3
Interaction between the Gene and Nutritional Factors on NAFLD Development: The Korean Genome and Epidemiology Study.
基因与营养因素在非酒精性脂肪性肝病发展中的相互作用:韩国基因组与流行病学研究。
Nutrients. 2022 Dec 28;15(1):152. doi: 10.3390/nu15010152.
4
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.非酒精性脂肪性肝病(NAFLD)的小鼠模型:发病机制和药物治疗。
Int J Biol Sci. 2022 Sep 6;18(15):5681-5697. doi: 10.7150/ijbs.65044. eCollection 2022.
5
The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review.宏量营养素在儿童非酒精性脂肪性肝病(NAFLD)发病机制、预防及治疗中的作用——综述
Life (Basel). 2022 Jun 5;12(6):839. doi: 10.3390/life12060839.
6
The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review.维生素在非酒精性脂肪性肝病中的作用:一项系统评价
Cureus. 2021 Aug 3;13(8):e16855. doi: 10.7759/cureus.16855. eCollection 2021 Aug.
7
Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis.Toll 样受体在肝硬化中识别肠道微生物。
Front Immunol. 2021 Feb 23;12:608498. doi: 10.3389/fimmu.2021.608498. eCollection 2021.
8
Associations Among Methylene Tetrahydrofolate Reductase rs1801133 Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese Population.中国人群中亚甲基四氢叶酸还原酶rs1801133基因变异、食物类别与非酒精性脂肪性肝病风险之间的关联
Front Genet. 2021 Feb 18;12:568398. doi: 10.3389/fgene.2021.568398. eCollection 2021.
9
The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease.乙醛脱氢酶2多态性与食物组摄入量及患非酒精性脂肪性肝病概率的关联与相互作用
Diabetes Metab Syndr Obes. 2020 Dec 22;13:5049-5057. doi: 10.2147/DMSO.S290491. eCollection 2020.
10
Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease.肠道微生物群的调节代表了非酒精性脂肪性肝病的一种新的治疗方法。
Hepatobiliary Surg Nutr. 2020 Apr;9(2):223-226. doi: 10.21037/hbsn.2019.10.01.